187 related articles for article (PubMed ID: 9066954)
1. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
[No Abstract] [Full Text] [Related]
2. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
3. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
4. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
Niendorf HP; Alhassan A; Geens VR; Clauss W
Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
[No Abstract] [Full Text] [Related]
5. Clinical safety of gadopentetate dimeglumine.
Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
[TBL] [Abstract][Full Text] [Related]
6. Laryngospasm after administration of gadopentetate dimeglumine.
Omohundro JE; Elderbrook MK; Ringer TV
J Magn Reson Imaging; 1992; 2(6):729-30. PubMed ID: 1446118
[TBL] [Abstract][Full Text] [Related]
7. Eye and testicular pain after administration of gadopentetate dimeglumine.
Padhani AR; Lopez AJ; Revell PB; MacVicar DA
AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
[No Abstract] [Full Text] [Related]
8. Severe adverse reaction to iv gadopentetate dimeglumine.
Takebayashi S; Sugiyama M; Nagase M; Matsubara S
AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
[No Abstract] [Full Text] [Related]
9. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
Tishler S; Hoffman JC
AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
[No Abstract] [Full Text] [Related]
10. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
[No Abstract] [Full Text] [Related]
11. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
Alhassan A; Weinmann HJ
AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
[No Abstract] [Full Text] [Related]
12. Generalized seizure after i.v. administration of gadopentetate dimeglumine.
Harbury OL
AJNR Am J Neuroradiol; 1991; 12(4):666. PubMed ID: 1882740
[No Abstract] [Full Text] [Related]
13. Can gadolinium be safely given in renal failure?
Weissleder R
AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
[No Abstract] [Full Text] [Related]
14. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Chanalet S; Masson B; Boyer L; Laffont J; Bruneton JN
J Radiol; 1995 Jul; 76(7):417-21. PubMed ID: 7473375
[TBL] [Abstract][Full Text] [Related]
15. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.
Matchett WJ; McFarland DR; Russell DK; Sailors DM; Moursi MM
Radiology; 1996 Nov; 201(2):569-71. PubMed ID: 8888260
[TBL] [Abstract][Full Text] [Related]
16. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
Kleinman PK; Ragland RL
AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
[No Abstract] [Full Text] [Related]
17. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
18. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
Eldevik OP; Brunberg JA
AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967
[TBL] [Abstract][Full Text] [Related]
19. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
Witte RJ; Anzai LL
AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
Mühler A; Saeed M; Brasch RC; Higgins CB
Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
